PSA concentration was strongly and positively associated with risk for prostate cancer, both with and without adjustment for MSP concentration (OR = 45.2, 95% CI 29.7–68.7, with adjustment for age, BMI and MSP; supplementary Table S4, available at Annals of Oncology online). Here, KLK3 is linked to prostate cancer.